Stephen Chappell Mitchell
18Patents
12h-index
8Co-inventors
67Inventor score
Filing activity: Jun 1, 1999 → Jun 13, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6329503A | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 91 | Expired |
| US7485299B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 44 | Active |
| US7053186B2 | Antibodies immunospecific for STEAP1 | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7037667B1 | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer | Physics | 33 | Expired |
| US8414898B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 33 | Active |
| US6887975B2 | Peptides derived from STEAP1 | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6833438B1 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 30 | Expired |
| US7166714B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 26 | Expired |
| US7642054B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US7611904B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US7928201B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US7968307B2 | Serpentine transmembrane antigens expressed in human cancers and uses thereof | Emerging Cross-Sectional Technologies | 14 | Active |
| US6509458B1 | Gene expressed in prostate cancer | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6652859B1 | PTANS: testis specific proteins expressed in prostate cancer | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8053551B2 | Serpentine transmembrane antigens expressed in human cancers and uses therefor | Emerging Cross-Sectional Technologies | 6 | Active |
| US7432346B2 | Gene expressed in prostate cancer | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7803916B2 | Gene expressed in prostate cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US7981624B2 | Methods to detect tumors using 20P1F12/TMPRSS2 expression | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.